Qingya Cui

861 total citations
42 papers, 298 citations indexed

About

Qingya Cui is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Qingya Cui has authored 42 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 17 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Qingya Cui's work include CAR-T cell therapy research (16 papers), Acute Myeloid Leukemia Research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Qingya Cui is often cited by papers focused on CAR-T cell therapy research (16 papers), Acute Myeloid Leukemia Research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Qingya Cui collaborates with scholars based in China, United States and Taiwan. Qingya Cui's co-authors include Xiaowen Tang, Yan Zhao, Yanhong Dong, Wentao Zhang, Ming Li, Feng Shi, Sheng Yan, Haiping Dai, Liqing Kang and Wei Cui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Frontiers in Immunology.

In The Last Decade

Qingya Cui

34 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingya Cui China	10	87	84	75	60	53	42	298
Dimitrios Pikazis Greece	9	66 0.8×	47 0.6×	84 1.1×	54 0.9×	39 0.7×	20	349
Filiz Vural Türkiye	8	49 0.6×	88 1.0×	66 0.9×	19 0.3×	27 0.5×	59	234
George Mo United States	8	165 1.9×	50 0.6×	89 1.2×	21 0.3×	19 0.4×	19	345
Anca Bojan Romania	10	84 1.0×	75 0.9×	53 0.7×	21 0.3×	19 0.4×	39	310
Blanca Molina Spain	11	100 1.1×	178 2.1×	44 0.6×	32 0.5×	14 0.3×	31	346
Mariana Ivanova Bulgaria	10	50 0.6×	59 0.7×	78 1.0×	33 0.6×	13 0.2×	46	367
Yoshihisa Morishita Japan	12	132 1.5×	210 2.5×	104 1.4×	53 0.9×	22 0.4×	36	414
Kang Zhou China	10	39 0.4×	144 1.7×	23 0.3×	64 1.1×	27 0.5×	68	290
Michał Mielnik Poland	10	69 0.8×	49 0.6×	32 0.4×	75 1.3×	17 0.3×	35	248

Countries citing papers authored by Qingya Cui

Since Specialization

Citations

This map shows the geographic impact of Qingya Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingya Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingya Cui more than expected).

Fields of papers citing papers by Qingya Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingya Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingya Cui. The network helps show where Qingya Cui may publish in the future.

Co-authorship network of co-authors of Qingya Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Qingya Cui. A scholar is included among the top collaborators of Qingya Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingya Cui. Qingya Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lei, Qingya Cui, Shuqi Wu, et al.. (2025). HSQC-guided discovery and structural optimization of antiadipogenic indole diterpenoids from endophytic fungus Penicillium janthinellum H-6. European Journal of Medicinal Chemistry. 297. 117956–117956.

Li, Lei, Qingya Cui, Qiong Liao, et al.. (2025). Sclerotiorin-Type Azaphilones Isolated from a Marine-Derived Fungus Microsphaeropsis arundinis P1B. Journal of Natural Products. 88(4). 1075–1084. 2 indexed citations

Cui, Qingya, Sining Liu, Wei Cui, et al.. (2024). Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients. Leukemia Research. 145. 107569–107569.

Zheng, Bo, Qingya Cui, Yiming Mao, et al.. (2024). Single‐Cell Spatial Transcriptomics Unveils Platelet‐Fueled Cycling Macrophages for Kidney Fibrosis. Advanced Science. 11(29). e2308505–e2308505. 9 indexed citations

Li, Yangzi, Qingya Cui, Lingling Liu, et al.. (2024). Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion. Cellular Oncology. 47(5). 1649–1661. 4 indexed citations

Li, Mengyun, Xiaoqian Chen, Juan Chen, et al.. (2024). How to Improve the Efficacy of Venetoclax and Azacitidine（VA）for Newly Diagnosed Acute Myeloid Leukemia？a Prospective, Single-Center, Single-Arm, Phase 2 Trial for New Diagnosed AML. Blood. 144(Supplement 1). 4284–4284. 1 indexed citations

Cui, Qingya, et al.. (2024). Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature. OncoTargets and Therapy. Volume 17. 733–738.

Cui, Qingya, Mengyun Li, Haiping Dai, et al.. (2024). Sequential Infusion of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cells: A Promising Treatment Strategy for Refractory Immune-Mediated Platelet Transfusion Refractoriness. Blood. 144(Supplement 1). 683–683.

Li, Yangzi, Sining Liu, Qingya Cui, et al.. (2023). Rituximab Improves Clinical Outcomes of CAR-T Therapy for r/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion. Blood. 142(Supplement 1). 6803–6803. 5 indexed citations

10.

Zhou, Xia, Ruiyu Liang, Yijing Zhao, et al.. (2023). Dendritic alloy shell Au@AgPt yolk sensor with excellent dual SERS enhancement and catalytic performance for in-situ SERS monitoring reaction. Sensors and Actuators B Chemical. 394. 134385–134385. 10 indexed citations

11.

Gu, Jingxian, Sining Liu, Wei Cui, et al.. (2022). Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy. Frontiers in Immunology. 13. 858590–858590. 6 indexed citations

12.

Cui, Qingya, Haiping Dai, Depei Wu, et al.. (2022). Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria. Frontiers in Medicine. 9. 854338–854338. 4 indexed citations

13.

Liu, Sining, Qingya Cui, Haiping Dai, et al.. (2021). Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(6). 481.e1–481.e7. 7 indexed citations

14.

Qian, Cheng, Wenying Yan, Tengda Li, et al.. (2018). Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis. Cellular Physiology and Biochemistry. 45(1). 301–318. 16 indexed citations

15.

Cui, Qingya, et al.. (2017). Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia. International Journal of Hematology. 107(1). 64–68. 9 indexed citations

16.

Cui, Qingya, et al.. (2015). Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature. Drug Design Development and Therapy. 9. 2395–2395. 3 indexed citations

17.

Cui, Qingya, et al.. (2014). Effective treatment with para-aminomethylbenzoic acid for chronic disseminated intravascular coagulation associated with aortic dissection. Blood Coagulation & Fibrinolysis. 26(3). 334–336. 5 indexed citations

18.

Chen, Haifei, Zhaoyue Wang, Zhiyong Luo, et al.. (2013). Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review. Drug Design Development and Therapy. 7. 767–767. 13 indexed citations

19.

Chen, Haifei, Zhengyang Li, Qingya Cui, et al.. (2012). Clinical Study of Thalidomide Combined with Dexamethasone for the Treatment of Elderly Patients with Newly Diagnosed Multiple Myeloma. Asian Pacific Journal of Cancer Prevention. 13(9). 4777–4781. 4 indexed citations

20.

Zhang, Wentao, Feng Shi, Sheng Yan, et al.. (2009). Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. Lara D. Veeken. 49(3). 571–577. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact